New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Here’s what the science says.

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

Add Yahoo as a preferred source to see more of our stories on Google. Image of 1.5 mg starter dose of Wegovy® pill (PRNewsfoto/NOVO NORDISK INC.) Novo Nordisk has launched the first once-daily GLP-1 ...

Add Yahoo as a preferred source to see more of our stories on Google. Having an oral version of the medication, which had only been available as an injectable until now, is a “very big deal,” says ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...

The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through ...